Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
121 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
122 Solubilization and Enhancement of Ex Vivo Vaginal Delivery of Progesterone Using Solid Dispersions, Inclusion Complexes and Micellar Solubilization 2018
123 Lipid-Coated Superparamagnetic Nanoparticles for Thermoresponsive Cancer Treatment 2018
124 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma 2018
125 High Payload Nanostructured Lipid Carriers Fabricated with Alendronate/Polyethyleneimine Ion Complexes 2018
126 ROLE OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS IN ENHANCING THE ORAL BIOAVAILABILITY OF BCS CLASS II DRUGS 2018
127 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
128 Solubilization and Enhancement of Ex Vivo Vaginal Delivery of Progesterone Using Solid Dispersions, Inclusion Complexes and Micellar Solubilization 2018
129 Lipid-Coated Superparamagnetic Nanoparticles for Thermoresponsive Cancer Treatment 2018
130 ROLE OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS IN ENHANCING THE ORAL BIOAVAILABILITY OF BCS CLASS II DRUGS 2018